Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can tiny fat bubbles in eye drops soothe dry eyes?

NCT ID NCT07793344

Disease control Sponsor: Regional Specialist Hospital in Wroclaw Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This trial tests whether an experimental eye drop made of tiny fat bubbles, called liposomes, can improve the health of the eye surface and tear film in adults with dry eye disease. Participants will use one drop in each eye three times a day for four weeks. Researchers will measure tear film stability, tear volume, and eye surface damage before and after treatment. The study aims to see if this approach can ease symptoms and improve eye comfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an experimental ophthalmic liposomal nanocarrier
What this could lead to
If it works, this could offer a new way to ease dry eye symptoms and improve tear film stability.
What could go wrong
This is a small, early-stage trial with no control group, so results may not be conclusive or generalizable. The eye drop may not provide meaningful relief or could cause irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Mar 2022

Finished

Jun 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older with dry eye disease diagnosed by an ophthalmologist. * Written informed consent. * Ability to attend baseline and follow-up assessments and use the study formulation for approximately four weeks. Exclusion Criteria: * Pregnancy * Breastfeeding * Ocular diseases or conditions considered by the examining ophthalmologist likely to interfere with study assessments or confound the study outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry eye disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dry eye disease

Contacts and locations

Locations

  • Regional Specialist Hospital in Wroclaw

    Wroclaw, 51-124, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.